Timothy Rolph
CIK 1779479 · Chief Scientific Officer · last filed 2025-12-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
47
Lifetime Open-Market Net
-$19.56M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) Delisted | Chief Scientific Officer | 0 | $54.65 | $0 | -$19.56M | 47 | 2025-12-09 |
Recent Filings · Page 4 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-21 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | −38,200 | -$4.26M | EDGAR |
| 2023-06-15 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −509 | -$28.1K | EDGAR |
| 2023-03-14 | Akero Therapeutics, Inc. (AKRO) Delisted | Tax (F) | −603 | -$26.2K | EDGAR |
| 2022-12-30 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | −12,500 | -$852.3K | EDGAR |
| 2022-12-20 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-13 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +19,195 | $0 | EDGAR |
| 2022-11-16 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −7,085 | -$320.8K | EDGAR |
| 2022-10-27 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | −12,500 | -$593.0K | EDGAR |
| 2022-10-27 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | −5,415 | -$591.7K | EDGAR |
| 2022-10-07 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | −12,500 | -$673.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.